Health and Healthcare

iBio Boasts Huge Production Capacity for Potential COVID-19 Vaccine

MarianVejcik / Getty Images

Shares of iBio Inc. (NYSE: IBIO) jumped on Tuesday after the company provided an update on its COVID-19 vaccine manufacturing capacity. At the same time, the company said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Management noted that if iBio’s own proprietary SARS-CoV-2 Virus-Like Particle (VLP) program, IBIO-200, results in an approved vaccine, it estimates that iBio could make about 500 million doses of high-quality product annually at its Texas facility. However, this depends on the potency that it sees in the clinic.

NIIMBL is a public-private partnership that aims to accelerate biopharmaceutical manufacturing innovations and establish an international, leading workforce to fundamentally strengthen the U.S. biopharmaceutical industry.

Tom Isett, co-chair and chief executive of iBio, commented:

That scalability links directly to the modular technology behind our FastPharming Manufacturing System, which uses a relative of the tobacco plant as the ‘bioreactor’ to produce biopharmaceuticals. So, the amount of product generated by a single plant is consistent from research- to commercial-scale, and scale-up is achieved by simply growing thousands more plants within our 130,000 square foot facility.  This is real innovation in the manufacture of biopharmaceuticals, thus our significant synergy with the NIIMBL community.

iBio stock traded up about 39% to $1.27 on Tuesday, in a 52-week range of $0.05 to $3.40. It has a market cap of roughly $130 million.

Travel Cards Are Getting Too Good To Ignore (sponsored)

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.